According to a national study released today, moms are feeling overwhelming pressure to overspend on products for their babies even as they significantly cut back in nearly every other area of their lives to cope with these challenging times.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54418-kelton-research-mom-study-baby-products-store-brand-infant-formula
The labour market shortfall caused by the decline in Europe’s population and workforce will not be offset by increasing immigration levels nor by higher fertility and productivity rates, delegates will be told at the Opening Conference of the 2012 European Year of Active Ageing and Solidarity between Generations in Copenhagen on 18 January. The only way forward, according to Eurofound, the EU-agency charged with providing European social policymakers with comparative socio-economic research data and findings, is more active and inclusive employment policies – as well as a change to the general mind-set – to extend working life.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53742-eurofound
Medela today announced the U.S. launch of Calma, a product designed exclusively for breastfed babies to support mothers in their breastfeeding journey. Calma is a research-based nipple used with a BPA-free breastmilk bottle designed to help babies to maintain their natural feeding behavior and transition from bottle back to breast with ease — a revolution for breastfeeding mothers.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53588-medela-announces-u-s-launch-of-calma-for-breastfeeding
Doctors at Children’s Hospital Boston are just another step closer to securing a cure for sickle cell disease thanks to a little help from some superstar friends. More than $1 million was raised in support of their research efforts on Sunday, January 15 during the “Play Without Pain: Children’s Sickle Cell Benefit,” a partnership with international megastar Celine Dion, Caesars Entertainment, AEG Live and Children’s Hospital Boston. Held at Caesars Palace, the evening included a performance of Celine Dion’s glamorous show directed by Grammy Awards producer Ken Ehrlich, including a touching tribute to sickle cell victims during her rendition of Billy Joel’s “Lullabye.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/54153-celine-dion-play-without-pain-children-s-sickle-cell-benefit
New research published by Palo Alto Networks™, the network security company, indicates explosive growth in global social networking and browser-based file sharing on corporate networks, with a 300 percent increase in active social networking (e.g., posting, applications) compared with activity during the same period in the latter half of 2010. The Palo Alto Networks Application Usage and Risk Report provides a global view into application usage based on assessments of the raw application traffic from more than 1,600 enterprises between April 2011 and November 2011.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52469-palo-alto-networks-social-networking-applications-growth-research
New findings from the St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project (PCGP) have helped identify the mechanism that makes the childhood eye tumor retinoblastoma so aggressive. The discovery explains why the tumor develops so rapidly while other cancers can take years or even decades to form.
The finding also led investigators to a new treatment target and possible therapy for the rare childhood tumor of the retina, the light-sensing tissue at the back of the eye. The study appears in the January 11 advance online edition of the scientific journal Nature.
To view Multimedia News Release, go to http://www.multivu.com/mnr/46767-st-jude-genome-project-treatment-childhood-eye-tumor-retinoblastoma
Researchers have discovered that a subtype of leukemia characterized by a poor prognosis is fueled by mutations in pathways distinctly different from a seemingly similar leukemia associated with a much better outcome. The findings from the St. Jude Children’s Research Hospital — Washington University Pediatric Cancer Genome Project (PCGP) highlight a possible new strategy for treating patients with this more aggressive cancer.
The work provides the first details of the genetic alterations fueling a subtype of acute lymphoblastic leukemia (ALL) known as early T-cell precursor ALL (ETP-ALL). The results suggest ETP-ALL has more in common with acute myeloid leukemia (AML) than with other subtypes of ALL. The study appears in the January 12 edition of the journal Nature.
To view Multimedia News Release, go to http://www.multivu.com/mnr/46768-st-jude-cancer-genome-sequencing-project-combat-aggressive-leukemia
http://www.SEORankSpecialist.com. Keyword Research Service - SEO Rank Specialist is your Comprehensive and Best Keyword Research Solution. Looking to Outsource your Keyword Research with the Best Keyword Search Service? Outsource to us! Our Approach leaves no stone unturned. We are not talking about 'stones' here though, but, rather our Very Important MONEY KEYWORDS!
http://www.usfreeads.com/596398-cls.html Wealthy affiliate gives you full access to all resources including one on one support, video tutorials, case studies, courses, tips, techniques, research tools, articles, guides, how to's, faqs and much more. You'll learn money making techniques you won't find anywhere else and Kyle and Carson are always adding valuable resources.
According to research released today by Chase Card Services, a division of JPMorgan Chase & Co. [NYSE: JPM], 2012 is shaping up to be the year of “do-it-yourself” among American consumers. From travel to fitness to managing money, the What’s on Your Slate? poll from Chase SlateSM with Blueprint® reveals that people are taking steps to achieve their goals – and have fun – on their own terms this year. For example, 46 percent will exercise at home or outdoors instead of at a gym or health club, and 59 percent will pamper themselves at home rather than making visits to a spa or salon.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53597-chase-card-services-poll-americans-embrace-do-it-yourself-lifestyle-diy
Gone are the daunting days of pacing the drugstore aisles and wasting hard-earned money on gimmicky products that simply don’t deliver as Daily Glow (www.dailyglow.com), a leading health and beauty authority, announces its first-annual Daily Glow Awards. After in-depth research, testing and analysis of thousands of products in the marketplace, the 85 carefully selected products have been declared first year winners and granted “Glow-Getter” status, an accolade recognizing the most inventive, state-of-the-art and truly original products of 2011 within six categories: Skin, Hair, Makeup, Hand/Foot/Nail Care, Biggest Breakthroughs and Editors’ Picks. The inaugural Daily Glow Award winners will be highlighted in an expansive editorial feature on DailyGlow.com/Awards beginning December 16, 2011.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53388-daily-glow-getter-awards-innovative-products-where-health-meets-beauty
Symptoms improved significantly in adults with the bleeding disorder hemophilia B following a single treatment with gene therapy developed by researchers at St. Jude Children’s Research Hospital in Memphis and demonstrated to be safe in a clinical trial conducted at the University College London (UCL) in the U.K.
The findings of the six-person study mark the first proof that gene therapy can reduce disabling, painful bleeding episodes in patients with the inherited blood disorder. Results of the Phase I study appear in the December 10 online edition of the New England Journal of Medicine. The research is also scheduled to be presented December 11 at the 53rd annual meeting of the American Society of Hematology in San Diego.
To view Multimedia News Release, go to http://www.multivu.com/mnr/46766-st-jude-children-s-research-hospital-gene-therapy-bleeding-disorder
